301096.SZ Stock Analysis
30
Uncovered
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. engages in the research and development of medicine and medical technology. The company is headquartered in Hangzhou, Zhejiang and currently employs 765 full-time employees. The company went IPO on 2021-12-20. The services provided by the Company mainly include entrusted R&D of pharmaceutical technology and transformation of independent R&D technological achievements. The entrusted R&D business provides integrated pharmaceutical R&D services such as pharmaceutical research, clinical trial and registration application for major pharmaceutical enterprises and pharmaceutical R&D investment enterprises. The transformation business of independent R&D technological achievements is based on the independent project research and development of drug R&D platform, and actively promote the transformation of independent R&D technological achievements after obtaining phased R&D achievements.